Literature DB >> 19458580

Endovascular techniques for treatment of carotid-cavernous fistula.

Joseph J Gemmete1, Sameer A Ansari, Dheeraj M Gandhi.   

Abstract

Carotid-cavernous fistulas (CCFs) are abnormal arteriovenous communications in the cavernous sinus. Direct CCFs result from a tear in the intracavernous carotid artery. Indirect CCFs generally occur spontaneously and cause more subtle signs. Direct CCFs, which typically have high flow, usually present with ocular-orbital venous congestive features and cephalic bruit. Indirect CCFs, which typically have low flow, present with similar but more muted clinical features. Direct CCFs are always treated with endovascular methods. The goal is to occlude the fistula but preserve the patency of the internal carotid artery (ICA). Agents include detachable coils or liquid embolic agents delivered transarterially or transvenously. Arterial porous or covered stents are often used adjunctively. In rare cases, the ICA must be occluded. Indirect CCFs are only treated if symptoms are intractable or intolerable or if vision is threatened. The goal is to interrupt the fistulous communications and decrease the pressure in the cavernous sinus. The traditional approach has been transarterial embolization with liquid agents, particularly n-butyl cyanoacrylate (n-BCA). However, the multiplicity of arterial feeders and the low success rate in occluding indirect CCFs by the arterial route has led to a preference for transvenous embolization, most commonly via the inferior petrosal sinus. If that sinus is impassable, alternative routes include the pterygoid venous plexus, superior petrosal sinus, facial vein, or ophthalmic veins. The cavernous sinus is occluded with coils, liquid embolic agents, or both. The use of ethylene vinyl alcohol copolymer (Onyx), an agent that may be superior to n-BCA because it may allow better distal fistula penetration. However, more safety and efficacy data must be accumulated. When experienced interventionalists are involved, the success rate for closing direct fistulas is 85%-99% and for closing indirect fistulas is 70%-78%. Serious complications are relatively infrequent.

Entities:  

Mesh:

Year:  2009        PMID: 19458580     DOI: 10.1097/WNO.0b013e3181989fc0

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  40 in total

1.  Use of onyx for transarterial balloon-assisted embolization of traumatic carotid cavernous fistulas: a report of 23 cases.

Authors:  Y Yu; Q Huang; Y Xu; B Hong; W Zhao; B Deng; Y Zhang; J Liu
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-05       Impact factor: 3.825

2.  Triple coaxial catheter technique for transfacial superior ophthalmic vein approach for embolization of dural carotid-cavernous fistula.

Authors:  M-H Yuen; K-M Cheng; Y-L Cheung; C-M Chan; S C H Yu; G K C Wong; W-S Poon
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

3.  Blind endovascular catheterization and direct access of an occluded superior ophthalmic vein for treatment of carotid cavernous fistula.

Authors:  Ali Alaraj; Bobby Kim; Gerald Oh; Victor Aletich
Journal:  BMJ Case Rep       Date:  2013-06-12

4.  Clinical images - a quarterly column: transorbital coil embolization of a carotid cavernous fistula.

Authors:  Ankit Pansara; James Michael Milburn; Michael Perry; Barrett Eubanks
Journal:  Ochsner J       Date:  2013

5.  Intercavernous sinus dural arteriovenous fistula successfully treated with transvenous embolization. a case report.

Authors:  I Loumiotis; H J Cloft; G Lanzino
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

6.  Endovascular treatment of carotid cavernous sinus fistula: A systematic review.

Authors:  Bora Korkmazer; Burak Kocak; Ercan Tureci; Civan Islak; Naci Kocer; Osman Kizilkilic
Journal:  World J Radiol       Date:  2013-04-28

7.  Late-Onset Abducens Nerve Palsy after Endovascular Treatment for Carotid-Cavernous Fistula: Two Case Reports.

Authors:  Yao-Lin Liu; Yun-Han Hsieh; Tzu-Hsun Tsai
Journal:  Neuroophthalmology       Date:  2014-05-14

8.  Carotid-Cavernous Fistula: A Rare but Treatable Cause of Rapidly Progressive Vision Loss.

Authors:  Luis Nicolas Gonzalez Castro; Rene A Colorado; Alyssa A Botelho; Suzanne K Freitag; James D Rabinov; Scott B Silverman
Journal:  Stroke       Date:  2016-07-12       Impact factor: 7.914

9.  Feasibility of Noninvasive Diagnosis and Treatment Planning in a Case Series with Carotid-Cavernous Fistula using High-Resolution Time-Resolved MR-Angiography with Stochastic Trajectories (TWIST) and Extended Parallel Acquisition Technique (ePAT 6) at 3 T.

Authors:  A Seeger; U Kramer; F Bischof; F Schuettauf; F Ebner; S Danz; U Ernemann; T-K Hauser
Journal:  Clin Neuroradiol       Date:  2014-03-06       Impact factor: 3.649

10.  Quantitative Measurements of Cerebral Circulation in Spontaneously Regressing Traumatic Carotid-Cavernous Sinus Fistula with Velocity-Encoded Magnetic Resonance Imaging.

Authors:  Ho Kyun Kim; Sung Won Youn; Jongmin Lee
Journal:  Clin Neuroradiol       Date:  2014-04-10       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.